Search:

Exact Keyword


Total 605 results.
Sort by Relevant
2016 Poland Surgical Procedure Volumes Database (2015-2025) (2016)
Pages | Exhibits | 2016 Analysis | Forecasts Through 2025 | Relavancy 1
This in-depth procedure volumes database quantifies current and forecast procedure volumes across a spectrum of medical segments[Read More]




2016 Denmark Surgical Procedure Volumes Database (2015-2025) (2016)
Pages | Exhibits | 2016 Analysis | Forecasts Through 2025 | Relavancy 1
This in-depth procedure volumes database quantifies current and forecast procedure volumes across a spectrum of medical segments i[Read More]




Global Neurostimulation Devices Market (2016)
313 Pages | 63 Exhibits | 2016 Analysis | Forecasts Through 2020 | Relavancy 1
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global neurostimulation devices market for more than 20 existing and emerging therapy areas. NEUROSTIMULATION MARKET HIGHLIGHTS The dynamic global neurostimulation devices market was valued at more than $3.9 billion in 2015 and is expected to grow at a healthy CAGR of 8.4% over the forecast period. The U.S. contributed the majority of sales, although the ROW share is climbing...[Read More]




2016 Singapore Surgical Procedure Volumes Database (2015-2025) (2016)
Pages | Exhibits | 2016 Analysis | Forecasts Through 2025 | Relavancy 1
This in-depth procedure volumes database quantifies current and forecast procedure volumes across a spectrum of medical segments in some of the most promising and emerging markets. Extensive primary and secondary research methods were used to develop this database. This product is maintained and refined by LSI analysts on a real-time basis and updates will be released on an annual basis. Customers have direct access to the LSI analyst team to discuss the data. Customers are able to request...[Read More]




South Africa Surgical Procedure Volumes Database (2015-2020) (0)
Pages | Exhibits | 0 Analysis | Forecasts Through 2020 | Relavancy 1
This in-depth procedure volumes database quantifies current and forecast procedure volumes across a spectrum of medical segments in some of the most promising and emerging markets. [Read More]




Global Spinal Implants Market (2015)
223 Pages | 51 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
Spine disorders are a leading driver of healthcare costs worldwide, and range in severity from mild pain and loss of feeling to extreme pain and paralysis. These disorders are primarily caused by degenerative conditions in the spine, deformity, tumors and trauma. Degenerative disc disease (DDD) typically is caused by gradual disc damage and often results in disc herniation and chronic back or neck pain; the disease is most common among otherwise healthy people in their 30s or 40s and affects...[Read More]




European Surgical Procedure Volumes (2015)
463 Pages | 84 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
This report presents the most common surgical procedures performed in select European countries, as well as an overview of the etiology and epidemiology of selected diseases/disorders, prevailing surgical approaches/techniques, and evolving procedural utilization trends. European countries covered by this report include France, Germany, Italy, Spain, and the United Kingdom. The forecast period covered by this report is for the years 2014 through 2019. Surgical procedures covered by this re...[Read More]




U.S. Patient Monitoring Devices Market (2015)
235 Pages | 85 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
This report provides a summary of the nearly $2 billion U.S. patient monitoring devices market, which (for the purposes of this report) includes the following 5 segments: i.) pulse oximetry, ii.) cerebral oximetry, iii.) brain function monitors, iv.) hemodynamic monitoring devices, and v.) multi-parameter vital signs monitoring systems. In 2014, the largest segment-vital signs monitors-comprised the vast majority of sales, at approximately 51.6% of the total market, followed by pulse oxim...[Read More]




U.S. Surgical Procedure Volumes (2015)
506 Pages | 95 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
The number of laparoscopic/percutaneous surgical procedures performed in the United States (U.S.) has been gradually expanding over the years, reflecting the steady migration of patients from acute care settings and open surgery. By the end of 2010, outpatient procedures accounted for more than 50% of all surgeries performed in the U.S., compared with an estimated 30% in 2000. This trend is expected to continue over the forecast period covered by this report, though at a somewhat slower pac...[Read More]




Asia-Pacific: Surgical Procedure Volumes (2015)
319 Pages | 127 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Product areas covered by the scope of this report include a discussion of healthcare trends in the Asia-Pacific countries covered by this report (Japan, China, South Korea, India, Thailand, Vietnam, Malaysia, and Australia), as well as detailed analysis of surgical procedure volumes in the region as a whole and in each individual country. Surgical procedures covered by this report include cardiovascular and peripheral vascular procedures (e.g., CABG, PTCA, congenital heart defect repair, hea...[Read More]




U.S. Neurostimulation Devices Market (2015)
277 Pages | 67 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
An estimated 200 million people in the United States (U.S.) experience some degree of neurological impairment over the course of a lifetime. Among the many neurological disorders are chronic pain (including migraine headache), epilepsy, hearing loss, incontinence, major depression, Parkinson's disease, sleep apnea, and visual impairment/blindness. Typically, the initial treatment option for these conditions is standard pharmacotherapy or surgery; however, neurostimulation is gaining in popu...[Read More]




U.S. Markets for Infection Control and Biosafety Products (2015)
96 Pages | 32 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Each year, approximately two million hospital patients in the United States (U.S.) acquire a healthcare-associated infection, or HAI. The most common HAIs are those of the lungs, surgical site, and urinary tract. Approximately one-third of all HAIs are considered preventable. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for infection control and biosafety products. Product areas ...[Read More]




Global Markets for Oxygen Therapy and Inhalation Devices (2015)
94 Pages | 57 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
The global market for oxygen therapy and inhalation devices was valued at $1.0 billion in 2014. As analyzed in this detailed new report by LSI, growth in developed markets, such as the U.S., has been profoundly shaped by trends in reimbursement. While cost-containment efforts by providers have threatened product manufacturers' margins, they have also spurred the adoption of technologies that reduce the need for frequent visits and facilitate more flexible lifestyles for patients, trends which...[Read More]




2015 Global Opportunities in Endovascular Management of Chronic Venous Insufficiency & Deep Vein Thrombosis (2015)
200 Pages | Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Chronic venous insufficiency (CVI) and deep vein thrombosis (DVT) are complex and challenging peripheral vascular conditions that affecting large segments of the global adult population. Although not usually as immediately life-threatening as a stroke or heart attack, their progressive nature can have serious long-term implications for affected individuals, who may develop debilitating secondary conditions that can be costly to treat and, in some cases, become life-threatening. Aside from l...[Read More]




U.S. Markets for Drug and Fluid Delivery Devices (2015)
180 Pages | 52 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S. To date, more than 40,000 prescription drug products containing 2,700 active ingredients have been approved by the FDA; these products accounted for more than 70% of the national pharmaceutical usage in 2014. In the same year, U.S. pharmacies processed nearly 4 billion prescriptions, generating more than $310.0 billion in cumu...[Read More]




Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies (2015)
106 Pages | 44 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
A new report from LSI, "Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies in 2015," explores the dynamic market for transdermal drug patches, iontophoresis devices, dry powder inhalers, metered dose inhalers, and nebulizers. The market, which was valued at $8.2 billion in 2014, is being driven by powerful regional and economic forces; key among these are the introduction and adoption of generic products, rising caseloads, the pursuit of new and expanded t...[Read More]




U.S. Markets for Obesity Drugs & Devices (2015)
178 Pages | 56 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
According to National Health and Nutrition Examination Survey (NHANES), approximately 35%, or nearly one out of three adults age 20 years or older were classified as obese in 2012 (the latest available statistics) based on a BMI of 30 kg/m2 or greater. This translates to more than 100 million obese people in the U.S.-a staggering number. Obesity has become such as concern due to increasing prevalence and the rise of serious health-related co-morbidities, such as type 2 diabetes, that it has r...[Read More]




U.S. Markets for Stroke Management (2015)
170 Pages | 44 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The United States (U.S.) market for stroke management products, which encompasses diagnostic and therapeutic systems, is a market composed of old and new technologies that are often used together in order to prevent and treat stroke. Improvements in stroke diagnostic systems will facilitate the delivery of timely stroke therapies within the optimum treatment window for patients suffering from stroke. Topics covered in this report include: •    Diagnostic, intervention...[Read More]




U.S. Markets for Biologic and Tissue Engineered Devices - Cardiovascular and Neurological Products (2015)
110 Pages | 13 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
Tissue engineering, or regenerative medicine, represents a promising therapeutic possibility for the treatment of aggressive and deadly diseases. Cellular therapies for cardiovascular disease (CVD) and neurological disease represent potential billion dollar markets that could offer a viable therapeutic option for a sizable patient population that has exhausted other therapeutic alternatives. Over 35 novel cellular therapies for cardiovascular and neurological disease are currently in develo...[Read More]




U.S. Markets for Cardiac Rhythm Management (2015)
118 Pages | 33 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Cardiac rhythm management (CRM) devices, which encompasses diagnostic and therapeutic systems, represents a well-established market that is still seeing innovation in some of the segments that compose it. Over the forecast period covered in this report, the estimated value of the U.S. market for CRM devices is expected to grow by approximately $1.1 billion at compound annual growth rate (CAGR) of 2.9%; of this holistic market, diagnostic CRM products are forecasted to grow at a CAGR of 4.8%,...[Read More]




Global Molecular Diagnostics Market (2015)
272 Pages | 59 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019. This growth is forecast to occur in spite of relatively modest growth in the overall worldwide market for IVD products, which is estimated to be expanding at a compound annual rate of 4.2% for the same period. To some extent, growth o...[Read More]




2015 Global Opportunities in Interventional Acute Stroke Therapies (2015)
200 Pages | Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The report covers emerging and existing neurointerventional technologies used in the management of patients with intracranial hemorrhage and acute cerebral ischemia. Special emphasis is given to novel left atrial appendage systems for the prevention of cardiogenic stroke (which accounts for about 20% of all acute ischemic stroke cases), and cerebral thrombectomy systems that address a large unmet need in the emergent treatment of acute ischemic stroke patients (less than 5% of the latter qua...[Read More]




2015 Global Opportunities in the Interventional Management of Symptomatic Peripheral Artery Disease (2015)
200 Pages | 66 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
This report focuses on the novel drug-coated balloon and drug-eluting stent technologies that are expected to revolutionize the treatment of limb- and life-threatening symptomatic peripheral artery disease and drive the development of a new, multi-billion dollar market. It also covers revascularization-enabling peripheral atherectomy systems and dedicated refractory CTO crossing devices that are likely to see above-average growth through 2019. Epidemiological, procedure and market data are ...[Read More]




2015 Global Opportunities in Endovascular Management of Aortic Aneurysm Disease (2015)
200 Pages | Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
This report is focused on primary and ancillary technologies employed in endovascular aortic aneurysm repair (EVAR). Commercially introduced about two decades ago, less invasive EVAR techniques quickly emerged as the preferred treatment modality for life-threatening, rupture-prone abdominal and thoracic aortic aneurisms in the U.S. and as a viable alternative to highly invasive and risky surgery in Europe and other regions of the world. By the end of 2014, cumulative global EVAR device revenu...[Read More]




U.S. Markets for Minimally Invasive Benign Prostatic Hyperplasia and Prostatitis Therapies (2015)
74 Pages | 15 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
In the United States (U.S.) benign prostatic hyperplasia (BPH) and prostatitis currently affect over 10 million men, lowering quality of life with painful symptoms that can be difficult to manage. The U.S. market for minimally invasive products for the treatment of BPH and prostatitis includes pharmaceutical and minimally invasive surgical systems aimed at treating the symptoms of BPH/prostatitis. New therapies in development offer the potential to change the way that symptomatic BPH and pr...[Read More]




U.S. Markets for Orthopedic Extremity and Soft Tissue Repair (2015)
138 Pages | 46 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The United States (U.S.) market for orthopedic extremity and soft tissue repair products encompasses interventional surgical procedures and biologic and synthetic implants used in the repair of bone, joints, and soft tissue that have been damaged as a result of disease or due to physical injury. Innovation in the treatment of bone, joint, and soft tissue of the extremities will primarily be seen in biologics, as new products are designed harnessing cellular therapies, such as stem cells, to ...[Read More]




U.S. Markets for Anesthesia and Ventilation Products (2015)
184 Pages | 62 Exhibits | 2015 Analysis | Forecasts Through 2018 | Relavancy 1
Respiratory care and anesthesia represent a significant element of healthcare delivery within the U.S. In 2013, the U.S. anesthesia and ventilation products market totaled approximately $3.5 billion. The overall market is expected to experience 4.5% growth over the forecast period, with the most growth anticipated in the heat/moisture exchangers and supraglottic airways segments. Factors contributing to growth in this market include the aging of the population (with an associated incre...[Read More]




2015 Hypertension and Resistant Hypertension Disease Dynamics Report (2015)
Pages | Exhibits | 2015 Analysis | Forecasts Through | Relavancy 1
In this report, Dymedex provides a detailed landscape of diseases far beyond what is currently available in the public domain. While individual clinical papers provide specific snapshots of a disease or strive to understand its epidemiology or other dimensions, no single clinical paper attempts to aggregate the hundreds of pieces of information that exist about a given disease and synthesize them into an integrated perspective. This report details the progression of a patient from undia...[Read More]




Global Markets for Gastrointestinal and Colorectal Endoscopy, Cystoscopy, Ureteroscopy, and Hysteroscopy (2015)
104 Pages | 67 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
This report explores the underlying forces driving growth in some of the most important endoscopic segments. At a time when healthcare institutions are seeking ways to restrain spending while improving outcomes, endoscopic technologies offer compelling possibilities by presenting improvements in cosmetic outcomes and the potential for faster recoveries-both of which are important considerations in a global market which features a growing middle class and rising awareness of th...[Read More]




Global Markets for Specialty Surgical Endoscopy Products (2015)
101 Pages | 62 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
The trend toward minimally-invasive surgery has driven rising sales of endoscopy products in a growing range of applications, including orthopedics, pulmonary and respiratory applications, urology, otolaryngology, gastrointestinal and colorectal surgery, neurology, and gynecology. Technological limitations and major anatomical challenges have limited adoption in important categories, however, preventing broader use of endoscopic devices and techniques for life-threatening applications in surg...[Read More]




Contact Us

Need help finding medtech research? Let us help you!